Chemical dissection of brain glucoregulatory circuitry

Molecular Neurosurgery With Targeted Toxins

Volumn , Issue , 2005, Pages 181-218

  Ritter, Sue ^a   Dinh, Thu T ^a   Bugarith, Kishor ^a   Salter, Dawna M ^b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750376581     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59259-896-0_8     Document Type: Chapter

References (93)

1. Sokoloff L. The metabolism of the central nervous system in vivo. In: Field J, Magoun HW, Hall VE, eds. Handbook of Physiology-Neurophysiology. Vol. 3. Washington, DC: American Physiological Society; 1960:1843-1864.
2. Fillenz M, Lowry JP, Boutelle MG, Fray AE. The role of astrocytes and nora-drenaline in neuronal glucose metabolism. Acta Physiol Scand 1999;167:275-284.
3. Picklo MJ, Wiley RG, Lappi DA, Robertson D. Noradrenergic lesioning with an anti-dopamine beta-hydroxylase immunotoxin. Brain Res 1994;666:195-200.
4. Picklo MJ, Wiley RG, Lonce S, Lappi DA, Robertson D. Anti-dopamine β-hydroxylase immunotoxin-induced sympathectomy in adult rats. J Pharmacol Exp Ther 1995;275:1003-1010.
5. Picklo MJ. Methods of sympathetic degeneration and alteration. J Auton Nerv Syst 1997;62:111-125.
6. Wrenn CC, Picklo MJ, Lappi DA, Robertson D, Wiley RG. Central noradren-ergic lesioning using anti-DBH-saporin: anatomical findings. Brain Res 1996;740:175-184.
7. Barthelemy I, Martineau D, Ong M, et al. The expression of saporin, a ribo-some-inactivating protein from the plant Saponaria officinalis, in Escherichia coli. J Biol Chem 1993;268:6541-6548.
8. Ritter RC, Slusser P. 5-Thio-D-glucose causes increased feeding and hypergly-cemia in the rat. Am J Physiol 1980;238:E141-E144.
9. Ritter S. Glucoprivation and the glucoprivic control of food intake. In: Ritter RC, Ritter S, Barnes CD, eds. Feeding Behavior: Neural and Humoral Controls. Orlando, FL: Academic Press Inc.; 1986:271-313.
10. Epstein AN, Nicolaidis S, Miselis RR. The glucoprivic control of food intake and the glucostatic theory of feeding behaviour. In: Mogenson GJ, Calaresu FR, eds. Neural Integration of Physiological Mechanisms and Behaviour. Toronto, Ontario, Canada: University of Toronto Press; 1975:148-168.
11. Slusser PG, Ritter RC. Increased feeding and hyperglycemia elicited by intracerebroventricular 5-thioglucose. Brain Res 1980;202:474-478.
12. Smith GP, Epstein AN. Increased feeding in response to decreased glucose utilization in the rat and monkey. Am J Physiol 1969;217:1083-1087.
13. Brown J. Effects of 2-deoxy-d-glucose on carbohydrate metabolism: review of the literature and studies in the rat. Metabolism 1962;11:1098-1112.
14. Chen M, Whistler RL. Action of 5-thio-D-glucose and its 1-phosphate with hex-okinase and phosphoglucomutase. Arch Biochem Biophys 1975;169:392-396.
15. Miselis RR, Epstein AN. Feeding induced by intracerebroventricular 2-deoxy-D-glucose in the rat. Am J Physiol 1975;229:1438-1447.
16. Berthoud HR, Mogenson GJ. Ingestive behavior after intracerebral and intracerebroventricular infusions of glucose and 2-deoxy-D-glucose. Am J Physiol 1977;233:R127-R133.
17. Flynn FW, Grill HJ. Insulin elicits ingestion in decerebrate rats. Science 1983;221:188-190.
18. Di Rocco RJ, Grill HJ. The forebrain is not essential for sympathoadrenal hy-perglycemic response to glucoprivation. Science 1979;204:1112-1114.
19. Ritter RC, Slusser PG, Stone S. Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science 1981;213:451-452.
20. Ritter S, Dinh TT, Zhang Y. Localization of hindbrain glucoreceptive sites controlling food intake and blood glucose. Brain Res 2000;856:37-47.
21. He B, White BD, Edwards GL, Martin RJ. Neuropeptide Y antibody attenuates 2-deoxy-D-glucose induced feeding in rats. Brain Res 1998;781:348-350.
22. Booth DA. Modulation of the feeding response to peripheral insulin, 2-deoxyglucose or 3-O-methyl glucose injection. Physiol Behav 1972;8:1069-1076.
23. Muller EE, Cocchi D, Mantegazza P. Brain adrenergic system in the feeding response induced by 2-deoxy-d-glucose. Am J Physiol 1972;223:945-950.
24. Sergeyev V, Broberger C, Gorbatyuk O, Hokfelt T. Effect of 2-mercaptoacetate and 2-deoxy-D-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocretin/orexin in the rat hypothalamus. Neuroreport 2000;11:117-121.
25. Fraley GS, Dinh TT, Ritter S. Immunotoxic catecholamine lesions attenuate 2DG-induced increase in AGRP mRNA. Peptides 2002;6397:1-8.
26. Fraley GS, Ritter S. Immunolesion of norepinephrine and epinephrine affer-ents to medial hypothalamus alters basal and 2DG-induced NPY and AGRP mRNA expression in the arcuate nucleus. Endocrinology 2003;144:75-83.
27. Brito NA, Brito MN, Kettelhut IC, Migliorini RH. Intra-ventromedial hypo-thalamic injection of cholinergic agents induces rapid hyperglycemia, hyperlactatemia and gluconeogenesis activation in fed, conscious rats. Brain Res 1993;626:339-342.
28. Coimbra CC, Migliorini RH. Evidence for a longitudinal pathway in rat hypo-thalamus that controls FFA mobilization. Am J Physiol 1983;245:E332-E337.
29. Steffens AB, Damsma G, van der Gugten J, Luiten PG. Circulating free fatty acids, insulin, and glucose during chemical stimulation of hypothalamus in rats. Am J Physiol 1984;247:E765-E771.
30. Bellin SI, Ritter S. Insulin-induced elevation of hypothalamic norepinephrine turnover persists after glucorestoration unless feeding occurs. Brain Res 1981;217:327-337.
31. Rowland NE. Effects of glucose and fat antimetabolites on norepinephrine turnover in rat hypothalamus and brainstem. Brain Res 1992;595:291-294.
32. Stricker EM, Friedman MI, Zigmond MJ. Glucoregulatory feeding by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions. Science 1975;189:895-897.
33. Epstein AN, Teitelbaum P. Specific loss of the hypoglycemic control of feeding in recovered lateral rats. Am J Physiol 1967;213:1159-1167.
34. Alheid GF, McDermott L, Kelly J, Halaris A, Grossman SP. Deficits in food and water intake after knife cuts that deplete striatal DA or hypothalamic NE in rats. Pharmacol Biochem Behav 1977;6:273-287.
35. Marshall JF, Richardson JS. Nigrostriatal bundle damage and the lateral hypo-thalamic syndrome. J Comp Physiol Psychol 1974;87:808-830.
36. Plotsky PM, Cunningham ET Jr, Widmaier EP. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr Rev 1989;10:437-458.
37. Plotsky PM, Otto S, Sutton S. Neurotransmitter modulation of corticotropin releasing factor secretion into the hypophysial-portal circulation. Life Sci 1987;41:1311-1317.
38. Whitnall MH, Kiss A, Aguilera G. Contrasting effects of central alpha-1-adrenoreceptor activation on stress-responsive and stress-nonresponsive sub-populations of corticotropin-releasing hormone neurosecretory cells in the rat. Neuroendocrinology 1993;58:42-48.
39. Whitnall MH. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 1993;40:573-629.
40. Leibowitz SF. Brain neuropeptide Y: an integrator of endocrine, metabolic and behavioral processes. Brain Res Bull 1991;27:333-337.
41. Smythe GA, Grunstein HS, Bradshaw JE, Nicholson MV, Compton PJ. Relationships between brain noradrenergic activity and blood glucose. Nature 1984;308:65-67.
42. Smythe GA, Edwards SR. A role for central postsynaptic a 2-adrenoceptors in glucoregulation. Brain Res 1991;562:225-229.
43. Smythe GA, Edwards SR. Suppression of central noradrenergic neuronal activity inhibits hyperglycemia. Am J Physiol 1992;263:E823-E827.
44. Leibowitz SF. Hypothalamic paraventricular nucleus: interaction between a 2-noradrenergic system and circulating hormones and nutrients in relation to energy balance. Neurosci Biobehav Rev 1988;12:101-109.
45. Leibowitz SF, Sladek C, Spencer L, Tempel D. Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: stimulation of feeding and the release of corticosterone, vasopressin and glucose. Brain Res Bull 1988;21:905-912.
46. Curran T, Morgan, JI. Fos: an immediate-early transcription factor in neurons. J Neurobiol 1995;26:403-412.
47. Wesselingh SL, Li YW, Blessing WW. PNMT-containing neurons in the rostral medulla oblongata (C1, C3 groups) are transneuronally labelled after injection of herpes simplex virus type 1 into the adrenal gland. Neurosci Lett 1989;106:99-104.
48. Strack AM, Sawyer WB, Platt KB, Loewy AD. CNS cell groups regulating the sympathetic outflow to adrenal gland as revealed by transneuronal cell body labeling with pseudorabies virus. Brain Res 1989;491:274-296.
49. Tucker DC, Saper CB, Ruggiero DA, Reis DJ. Organization of central adrener-gic pathways: I. Relationships of ventrolateral medullary projections to the hypothalamus and spinal cord. J Comp Neurol 1987;259:591-603.
50. Sawchenko PE, Swanson LW. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res 1982;257:275-325.
51. Jonsson G. Chemical lesioning techniques: monoamine neurotoxins. In: Bjorklund A, Hokfelt T, eds. Handbook of Chemical Neuroanatomy: Methods in Chemical Neuroanatomy. Vol. 1: New York: Elsevier Science Publishers; 1983:463-507.
52. Oltmans GA, Lorden JF, Margules DL. Food intake and body weight: effects of specific and non-specific lesions in the midbrain path of the ascending nora-drenergic neurons of the rat. Brain Res 1977;128:293-308.
53. Ahlskog JE, Randall PK, Hoebel BG. Hypothalamic hyperphagia: dissociation from hyperphagia following destruction of noradrenergic neurons. Science 1975;190:399-401.
54. Marshall JF, Richardson JS, Teitelbaum P. Nigrostriatal bundle damage and the lateral hypothalamic syndrome. J Comp Physiol Psychol 1974;87:808-830.
55. Jonsson G, Fuxe K, Hokfelt T, Goldstein M. Resistance of central phenylethanolamine-n-methyl transferase containing neurons to 6-hydroxydopamine. Med Biol 1976;54:421-426.
56. Blessing WW, Lappi DA, Wiley RG. Destruction of locus coeruleus neuronal perikarya after injection of anti-dopamine-β-hydroxylase immunotoxin into the olfactory bulb of the rat. Neurosci Lett 1998;243:85-88.
57. Westlund KN, Bowker RM, Ziegler MG, Coulter JD. Noradrenergic projections to the spinal cord of the rat. Brain Res 1983;263:15-31.
58. Cunningham ET Jr, Bohn MC, Sawchenko PE. Organization of adrenergic inputs to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Comp Neurol 1990;292:651-667.
59. Ritter S, Bugarith K, Dinh TT. Immunotoxic destruction of distinct catechola-mine subgroups produces selective impairment of glucoregulatory responses and neuronal activation. J Comp Neurol 2001;432:197-216.
60. Schreihofer AM, Guyenet PG. Sympathetic reflexes after depletion of bulbospinal catecholaminergic neurons with anti-DβH-saporin. Am J Physiol Regul Integr Comp Physiol 2000;279:R729-R742.
61. Ritter S, Watts AG, Dinh TT, Sanchez-Watts G, Pedrow C. Immunotoxin lesion of hypothalamically projecting norepinephrine and epinephrine neurons differentially affects circadian and stressor-stimulated corticosterone secretion. Endocrinology 2003;144:1357-1367.
62. Ritter S, Taylor JS. Vagal sensory neurons are required for lipoprivic but not glucoprivic feeding in rats. Am J Physiol 1990;258:R1395-R1401.
63. Scharrer E, Langhans W. Control of food intake by fatty acid oxidation. Am J Physiol 1986;250:R1003-R1006.
64. Hudson B, Ritter S. Hindbrain catecholamine neurons mediate consummatory responses to glucoprivation. Physiol Behav 2004;82:241-250.
65. Shor-Posner G, Azar AP, Insinga S, Leibowitz SF. Deficits in the control of food intake after hypothalamic paraventricular nucleus lesions. Physiol Behav 1985;35:883-890.
66. Calingasan NY, Ritter S. Hypothalamic paraventricular nucleus lesions do not abolish glucoprivic or lipoprivic feeding. Brain Res 1992;595:25-31.
67. Stanley BG, Leibowitz SF. Neuropeptide Y injected in the paraventricular hy-pothalamus: a powerful stimulant of feeding behavior. Proc Natl Acad Sci U S A 1985;82:3940-3943.
68. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hy-perphagia and obesity. Peptides 1986;7:1189-1192.
69. Hagan MM, Benoit SC, Rushing PA, Pritchard LM, Woods SC, Seeley RJ. Immediate and prolonged patterns of agouti-related peptide-(83-132)-induced c-Fos activation in hypothalamic and extrahypothalamic sites. Endocrinology 2001;142:1050-1056.
70. Hagan MM, Rushing PA, Pritchard LM, et al. Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am J Physiol Regul Integr Comp Physiol 2000;279:R47-R52.
71. Rossi M, Kim MS, Morgan DG, et al. A C-terminal fragment of agouti-related protein increases feeding and antagonizes the effect of a-melanocyte stimulating hormone in vivo. Endocrinology 1998;139:4428-4431.
72. Akabayashi A, Zaia CT, Silva I, Chae HJ, Leibowitz SF. Neuropeptide Y in the arcuate nucleus is modulated by alterations in glucose utilization. Brain Res 1993;621:343-348.
73. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999;20:68-100.
74. Oomura Y, Ooyama H, Sugimori M, Nakamura T, Yamada Y. Glucose inhibition of the glucose-sensitive neurone in the rat lateral hypothalamus. Nature 1974;247:284-286.
75. Oomura Y. Glucose as a regulator of neuronal activity. Adv Metab Disord 1983;10:31-65.
76. Levin BE. Glucosensing neurons do more than just sense glucose. Int J Obes Relat Metab Disord 2001;25(suppl 5):S68-S72.
77. Levin BE, Dunn-Meynell AA, Routh VH. Brain glucosensing and the K (ATP) channel. Nat Neurosci 2001;4:459-460.
78. Lynch RM, Tompkins LS, Brooks HL, Dunn-Meynell AA, Levin BE. Localization of glucokinase gene expression in the rat brain. Diabetes 2000;49:693-700.
79. Sawchenko PE, Swanson LW. Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J Comp Neurol 1982;205:260-272.
80. Guy J, Pelletier G. Neuronal interactions between neuropeptide Y (NPY) and catecholaminergic systems in the rat arcuate nucleus as shown by dual immu-nocytochemistry. Peptides 1988;9:567-570.
81. Broberger C, Johansen J, Johansson C, Schalling M, Hokfelt T. The neuropep-tide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 1998;95:15, 043-15, 048.
82. Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 1997;20:78-84.
83. Van de Kar LD, Blair ML. Forebrain pathways mediating stress-induced hormone secretion. Front Neuroendocrinol 1999;20:1-48.
84. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300:230-235.
85. Levin BE, Sullivan AC. Glucose, insulin and sympathoadrenal activation. J Auton Nerv Syst 1987;20:233-242.
86. Rappaport EB, Young JB, Landsberg L. Effects of 2-deoxy-D-glucose on the cardiac sympathetic nerves and the adrenal medulla in the rat: further evidence for a dissociation of sympathetic nervous system and adrenal medullary responses. Endocrinology 1982;110:650-656.
87. Schneider JE, Goldman MD, Leo NA, Rosen ME. Central vs peripheral metabolic control of estrous cycles in Syrian hamsters. II. Glucoprivation. Am J Physiol 1997;272:R406-R412.
88. Abizaid A, Jafferali S, Pelletier JG, Woodside B. Effect of metabolic fuel availability on fertility varies with reproductive state. Physiol Behav 2001;74:77-83.
89. I'Anson H, Starer CA, Bonnema KR. Glucoprivic regulation of estrous cycles in the rat. Horm Behav 2003;43:388-393.
90. Nagatani S, Bucholtz DC, Murahashi K, et al. Reduction of glucose availability suppresses pulsatile luteinizing hormone release in female and male rats. Endocrinology 1996;137:1166-1170.
91. Bucholtz DC, Vidwans NM, Herbosa CG, Schillo KK, Foster DL. Metabolic interfaces between growth and reproduction. V. Pulsatile luteinizing hormone secretion is dependent on glucose availability. Endocrinology 1996;137:601-607.
92. Murahashi K, Bucholtz DC, Nagatani S, et al. Suppression of luteinizing hormone pulses by restriction of glucose availability is mediated by sensors in the brain stem. Endocrinology 1996;137:1171-1176.
93. I'Anson H, Sundling LA, Roland SM, Ritter S. Immunotoxic destruction of distinct catecholaminergic neuron populations disrupts the reproductive response to glucoprivation in female rats. Endocrinology 2003;144:4325-4331.